Summary

Bovine Blood Plasma Derivatives Market – Scope of Report
TMR’s report on the global bovine blood plasma derivatives market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global bovine blood plasma derivatives market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bovine blood plasma derivatives market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the bovine blood plasma derivatives market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bovine blood plasma derivatives market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bovine blood plasma derivatives market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bovine blood plasma derivatives market.

The report delves into the competitive landscape of the global bovine blood plasma derivatives market. Key players operating in the global bovine blood plasma derivatives market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bovine blood plasma derivatives market profiled in this report.

Key Questions Answered in Global bovine blood plasma derivatives Market Report
• What is the sales/revenue generated by bovine blood plasma derivatives across all regions during the forecast period?
• What are the opportunities in the global bovine blood plasma derivatives market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Bovine Blood Plasma Derivatives Market – Research Objectives and Research Approach
The comprehensive report on the global bovine blood plasma derivatives market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global bovine blood plasma derivatives market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bovine blood plasma derivatives market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bovine Blood Plasma Derivatives Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2020-2034
4.4.1. Market Revenue Projections (US$ Bn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Value Chain Analysis
5.1.1. Prominent Companies in Bovine Blood Plasma Derivatives Value Chain
5.1.2. List of Key End-user
5.2. Porters Five Forces of Analysis
5.3. Price trend of raw material bovine plasma from 2010-2030
5.4. Global Bovine Blood Plasma Derivatives: Demand and Supply Scenario
5.5. Regulatory Scenarios
5.6. Key Industry Events
5.7. Technology Overview
5.7.1. Overview of Bovine Blood Plasma Derivatives Process
5.7.1.1. Bovine Serum Albumin (BSA)
5.7.1.2. Immunoglobulin
5.7.1.3. Fetal Bovine Serum (FBS)
5.7.1.4. Technology -Summary of blood collection and processing methods
5.7.2. Overview of Bovine Blood Plasma Yield
5.8. Distributors Landscape
5.9. Major Brand Analysis
5.10. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Kits and Reagents
6.3.2. Instruments
6.3.3. Software and Service
6.4. Market Attractiveness Analysis, by Product
7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. Molecular Diagnostics
7.3.2. Hematology
7.3.3. Immunodiagnostics
7.3.4. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Derivative Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Derivative Type, 2020-2034
8.3.1. Immunoglobulin
8.3.2. Fibrinogen
8.3.3. Serum Albumin
8.3.4. Fetal Bovine Serum
8.3.5. Thrombin
8.3.6. Transferrin
8.3.7. Others
8.4. Market Attractiveness Analysis, by Derivative Type
9. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Source
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Source, 2020-2034
9.3.1. US Grade
9.3.2. Australia Grade
9.3.3. New Zealand Grade
9.3.4. Others
9.4. Market Attractiveness Analysis, by Source
10. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020-2034
10.3.1. Veterinary Industry
10.3.1.1. Veterinary Hospitals
10.3.1.2. Veterinary Reference Laboratories
10.3.1.3. POC/In House Testing
10.3.1.4. Veterinary Research laboratories
10.3.2. Food Industry
10.3.3. Academic and Research Institutes
10.3.4. Cell Culture/ Biotechnology
10.3.5. Cosmetic Industry
10.3.6. Pharmaceutical Industry
10.3.7. Diagnostics Industry
10.3.8. Others
10.4. Market Attractiveness Analysis, by End-user
11. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020-2034
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2020-2034
12.2.1. Kits and Reagents
12.2.2. Instruments
12.2.3. Software and Service
12.3. Market Value Forecast, by Technology, 2020-2034
12.3.1. Molecular Diagnostics
12.3.2. Hematology
12.3.3. Immunodiagnostics
12.3.4. Others
12.4. Market Value Forecast, by Derivative Type, 2020-2034
12.4.1. Immunoglobulin
12.4.2. Fibrinogen
12.4.3. Serum Albumin
12.4.4. Fetal Bovine Serum
12.4.5. Thrombin
12.4.6. Transferrin
12.4.7. Others
12.5. Market Value Forecast, by Source, 2020-2034
12.5.1. US Grade
12.5.2. Australia Grade
12.5.3. New Zealand Grade
12.5.4. Others
12.6. Market Value Forecast, by End-user, 2020-2034
12.6.1. Veterinary Industry
12.6.1.1. Veterinary Hospitals
12.6.1.2. Veterinary Reference Laboratories
12.6.1.3. POC/In House Testing
12.6.1.4. Veterinary Research laboratories
12.6.2. Food Industry
12.6.3. Academic and Research Institutes
12.6.4. Cell Culture/ Biotechnology
12.6.5. Cosmetic Industry
12.6.6. Pharmaceutical Industry
12.6.7. Diagnostics Industry
12.6.8. Others
12.7. Market Value Forecast, by Country, 2020-2034
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Technology
12.8.3. By Derivative Type
12.8.4. By Source
12.8.5. By End-user
12.8.6. By Country
13. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2020-2034
13.2.1. Kits and Reagents
13.2.2. Instruments
13.2.3. Software and Service
13.3. Market Value Forecast, by Technology, 2020-2034
13.3.1. Molecular Diagnostics
13.3.2. Hematology
13.3.3. Immunodiagnostics
13.3.4. Others
13.4. Market Value Forecast, by Derivative Type, 2020-2034
13.4.1. Immunoglobulin
13.4.2. Fibrinogen
13.4.3. Serum Albumin
13.4.4. Fetal Bovine Serum
13.4.5. Thrombin
13.4.6. Transferrin
13.4.7. Others
13.5. Market Value Forecast, by Source, 2020-2034
13.5.1. US Grade
13.5.2. Australia Grade
13.5.3. New Zealand Grade
13.5.4. Others
13.6. Market Value Forecast, by End-user, 2020-2034
13.6.1. Veterinary Industry
13.6.1.1. Veterinary Hospitals
13.6.1.2. Veterinary Reference Laboratories
13.6.1.3. POC/In House Testing
13.6.1.4. Veterinary Research laboratories
13.6.2. Food Industry
13.6.3. Academic and Research Institutes
13.6.4. Cell Culture/ Biotechnology
13.6.5. Cosmetic Industry
13.6.6. Pharmaceutical Industry
13.6.7. Diagnostics Industry
13.6.8. Others
13.7. Market Value Forecast, by Country/Sub-region, 2020-2034
13.7.1. Germany
13.7.2. UK
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Technology
13.8.3. By Derivative Type
13.8.4. By Source
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2020-2034
14.2.1. Kits and Reagents
14.2.2. Instruments
14.2.3. Software and Service
14.3. Market Value Forecast, by Technology, 2020-2034
14.3.1. Molecular Diagnostics
14.3.2. Hematology
14.3.3. Immunodiagnostics
14.3.4. Others
14.4. Market Value Forecast, by Derivative Type, 2020-2034
14.4.1. Immunoglobulin
14.4.2. Fibrinogen
14.4.3. Serum Albumin
14.4.4. Fetal Bovine Serum
14.4.5. Thrombin
14.4.6. Transferrin
14.4.7. Others
14.5. Market Value Forecast, by Source, 2020-2034
14.5.1. US Grade
14.5.2. Australia Grade
14.5.3. New Zealand Grade
14.5.4. Others
14.6. Market Value Forecast, by End-user, 2020-2034
14.6.1. Veterinary Industry
14.6.1.1. Veterinary Hospitals
14.6.1.2. Veterinary Reference Laboratories
14.6.1.3. POC/In House Testing
14.6.1.4. Veterinary Research laboratories
14.6.2. Food Industry
14.6.3. Academic and Research Institutes
14.6.4. Cell Culture/ Biotechnology
14.6.5. Cosmetic Industry
14.6.6. Pharmaceutical Industry
14.6.7. Diagnostics Industry
14.6.8. Others
14.7. Market Value Forecast, by Country/Sub-region, 2020-2034
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By Technology
14.8.3. By Derivative Type
14.8.4. By Source
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2020-2034
15.2.1. Kits and Reagents
15.2.2. Instruments
15.2.3. Software and Service
15.3. Market Value Forecast, by Technology, 2020-2034
15.3.1. Molecular Diagnostics
15.3.2. Hematology
15.3.3. Immunodiagnostics
15.3.4. Others
15.4. Market Value Forecast, by Derivative Type, 2020-2034
15.4.1. Immunoglobulin
15.4.2. Fibrinogen
15.4.3. Serum Albumin
15.4.4. Fetal Bovine Serum
15.4.5. Thrombin
15.4.6. Transferrin
15.4.7. Others
15.5. Market Value Forecast, by Source, 2020-2034
15.5.1. US Grade
15.5.2. Australia Grade
15.5.3. New Zealand Grade
15.5.4. Others
15.6. Market Value Forecast, by End-user, 2020-2034
15.6.1. Veterinary Industry
15.6.1.1. Veterinary Hospitals
15.6.1.2. Veterinary Reference Laboratories
15.6.1.3. POC/In House Testing
15.6.1.4. Veterinary Research laboratories
15.6.2. Food Industry
15.6.3. Academic and Research Institutes
15.6.4. Cell Culture/ Biotechnology
15.6.5. Cosmetic Industry
15.6.6. Pharmaceutical Industry
15.6.7. Diagnostics Industry
15.6.8. Others
15.7. Market Value Forecast, by Country/Sub-region, 2020-2034
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By Technology
15.8.3. By Derivative Type
15.8.4. By Source
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product, 2020-2034
16.2.1. Kits and Reagents
16.2.2. Instruments
16.2.3. Software and Service
16.3. Market Value Forecast, by Technology, 2020-2034
16.3.1. Molecular Diagnostics
16.3.2. Hematology
16.3.3. Immunodiagnostics
16.3.4. Others
16.4. Market Value Forecast, by Derivative Type, 2020-2034
16.4.1. Immunoglobulin
16.4.2. Fibrinogen
16.4.3. Serum Albumin
16.4.4. Fetal Bovine Serum
16.4.5. Thrombin
16.4.6. Transferrin
16.4.7. Others
16.5. Market Value Forecast, by Source, 2020-2034
16.5.1. US Grade
16.5.2. Australia Grade
16.5.3. New Zealand Grade
16.5.4. Others
16.6. Market Value Forecast, by End-user, 2020-2034
16.6.1. Veterinary Industry
16.6.1.1. Veterinary Hospitals
16.6.1.2. Veterinary Reference Laboratories
16.6.1.3. POC/In House Testing
16.6.1.4. Veterinary Research laboratories
16.6.2. Food Industry
16.6.3. Academic and Research Institutes
16.6.4. Cell Culture/ Biotechnology
16.6.5. Cosmetic Industry
16.6.6. Pharmaceutical Industry
16.6.7. Diagnostics Industry
16.6.8. Others
16.7. Market Value Forecast, by Country/Sub-region, 2020-2034
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Product
16.8.2. By Technology
16.8.3. By Derivative Type
16.8.4. By Source
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis, by Company (2023)
17.3. Company Profiles
17.3.1. ANZCO Foods (Itoham Yonekyu Holdings)
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategies
17.3.1.5. Recent Developments
17.3.2. Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare)
17.3.2.1. Company Overview
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. Business Strategies
17.3.2.5. Recent Developments
17.3.3. Moregate Biotech (ANZCO Foods)
17.3.3.1. Company Overview
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. Business Strategies
17.3.3.5. Recent Developments
17.3.4. Proliant Health & Biologicals
17.3.4.1. Company Overview
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. Business Strategies
17.3.4.5. Recent Developments
17.3.5. LAMPIRE Biological Laboratories, Inc.
17.3.5.1. Company Overview
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. Business Strategies
17.3.5.5. Recent Developments
17.3.6. Rocky Mountain Biologicals, LLC
17.3.6.1. Company Overview
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. Business Strategies
17.3.6.5. Recent Developments
17.3.7. Thermo Fisher Scientific Inc.
17.3.7.1. Company Overview
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. Business Strategies
17.3.7.5. Recent Developments
17.3.8. Sigma-Aldrich (Merck KGaA)
17.3.8.1. Company Overview
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. Business Strategies
17.3.8.5. Recent Developments
17.3.9. Kraeber & Co GmbH
17.3.9.1. Company Overview
17.3.9.2. Financial Overview
17.3.9.3. Product Portfolio
17.3.9.4. Business Strategies
17.3.9.5. Recent Developments
17.3.10. Auckland BioSciences
17.3.10.1. Company Overview
17.3.10.2. Financial Overview
17.3.10.3. Product Portfolio
17.3.10.4. Business Strategies
17.3.10.5. Recent Developments
17.3.11. Lake Immunogenics
17.3.11.1. Company Overview
17.3.11.2. Financial Overview
17.3.11.3. Product Portfolio
17.3.11.4. Business Strategies
17.3.11.5. Recent Developments